Home NDC 44087-5000 TEPMETKO
Product NDC 44087-5000
11-digit product format 440875000
Labeler code 44087
Product ID 44087-5000_d922de79-b0f0-4ed2-b551-c7a86ed72d7d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Tepotinib Hydrochloride
Dosage form TABLET
Route ORAL
Labeler EMD Serono, Inc.
Application NDA214096
Marketing category NDA
Marketing start 2021-02-03
Substance TEPOTINIB HYDROCHLORIDE
Active strength 225 mg/1
Pharmacologic classes Kinase Inhibitor [EPC], Mesenchymal Epithelial Transition Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N214096-001 TEPMETKO TEPOTINIB HYDROCHLORIDE EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03
Orange Book patents# Current patent rows page 1 of 1 · 8 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N214096-001 9284300 2028-04-29 Drug product 2021-03-03 N214096-001 8921357 2028-05-30 Drug substance, Drug product 2021-03-03 N214096-001 8658643 2028-07-04 U-3077 2021-03-03 N214096-001 9062029 2028-07-04 Drug product 2021-03-03 N214096-001 9403799 2028-07-04 U-3077 2021-03-03 N214096-001 8927540 2028-07-21 U-3078 2021-03-03 N214096-001 8329692 2029-10-30 Drug substance, Drug product 2021-03-03 N214096-001 8580781 2030-03-19 Drug substance, Drug product 2021-03-03
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N214096-001 NCE 2026-02-03 N214096-001 ODE-325 2028-02-03
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 87673890dc5c…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N214096-001 TEPMETKO EQ 225MG BASE TABLET / ORAL RLD, RS 2021-02-03 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 7 · 272 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N214096-001 9284300 2028-04-29 Drug product 2021-03-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214096-001 8921357 2028-05-30 Drug substance, Drug product 2021-03-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214096-001 8658643 2028-07-04 U-3077 2021-03-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214096-001 9062029 2028-07-04 Drug product 2021-03-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214096-001 9403799 2028-07-04 U-3077 2021-03-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214096-001 8927540 2028-07-21 U-3078 2021-03-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214096-001 8329692 2029-10-30 Drug substance, Drug product 2021-03-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214096-001 8580781 2030-03-19 Drug substance, Drug product 2021-03-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214096-001 9284300 2028-04-29 Drug product 2021-03-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214096-001 8921357 2028-05-30 Drug substance, Drug product 2021-03-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214096-001 8658643 2028-07-04 U-3077 2021-03-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214096-001 9062029 2028-07-04 Drug product 2021-03-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214096-001 9403799 2028-07-04 U-3077 2021-03-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214096-001 8927540 2028-07-21 U-3078 2021-03-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214096-001 8329692 2029-10-30 Drug substance, Drug product 2021-03-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214096-001 8580781 2030-03-19 Drug substance, Drug product 2021-03-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N214096-001 9284300 2028-04-29 Drug product 2021-03-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214096-001 8921357 2028-05-30 Drug substance, Drug product 2021-03-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214096-001 8658643 2028-07-04 U-3077 2021-03-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214096-001 9062029 2028-07-04 Drug product 2021-03-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214096-001 9403799 2028-07-04 U-3077 2021-03-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214096-001 8927540 2028-07-21 U-3078 2021-03-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214096-001 8329692 2029-10-30 Drug substance, Drug product 2021-03-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214096-001 8580781 2030-03-19 Drug substance, Drug product 2021-03-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214096-001 9284300 2028-04-29 Drug product 2021-03-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214096-001 8921357 2028-05-30 Drug substance, Drug product 2021-03-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214096-001 8658643 2028-07-04 U-3077 2021-03-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214096-001 9062029 2028-07-04 Drug product 2021-03-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214096-001 9403799 2028-07-04 U-3077 2021-03-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214096-001 8927540 2028-07-21 U-3078 2021-03-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214096-001 8329692 2029-10-30 Drug substance, Drug product 2021-03-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214096-001 8580781 2030-03-19 Drug substance, Drug product 2021-03-03 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214096-001 9284300 2028-04-29 Drug product 2021-03-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214096-001 8921357 2028-05-30 Drug substance, Drug product 2021-03-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214096-001 8658643 2028-07-04 U-3077 2021-03-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214096-001 9062029 2028-07-04 Drug product 2021-03-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214096-001 9403799 2028-07-04 U-3077 2021-03-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214096-001 8927540 2028-07-21 U-3078 2021-03-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214096-001 8329692 2029-10-30 Drug substance, Drug product 2021-03-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214096-001 8580781 2030-03-19 Drug substance, Drug product 2021-03-03 b8a1b40f171c…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 68 observed states.
Additional Listing Data#
Finished product Yes
Brand name base TEPMETKO
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TEPOTINIB HYDROCHLORIDE 225 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination VY5YX2TQ1F Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2477266 Internal RxNorm lookup 2477272 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 44087-5000-3 TEPMETKO 3 in 1 CARTON TABLET 3 8 44087-5000-3 TEPMETKO 10 in 1 BLISTER PACK TABLET 10 8 44087-5000-6 TEPMETKO 10 in 1 BLISTER PACK TABLET 10 8 44087-5000-6 TEPMETKO 6 in 1 CARTON TABLET 6 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 44087-5000 TEPMETKO (TEPOTINIB HYDROCHLORIDE) TABLET [EMD SERONO, INC.] 8 Current NDC, Legacy NDC, 4 package rows 20250422_80a0f1b9-071a-47f5-9e67-32d638a669dc.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 44087-5000-3 44087500003 3 BLISTER PACK in 1 CARTON (44087-5000-3) / 10 TABLET in 1 BLISTER PACK 3 blister pack 2021-02-03 0000-00-00 No No Current 44087-5000-6 44087500006 6 BLISTER PACK in 1 CARTON (44087-5000-6) / 10 TABLET in 1 BLISTER PACK 6 blister pack 2021-02-03 0000-00-00 No No Current